Combination therapy with rituximab, low-dose cyclophosphamide, and prednisone for idiopathic membranous nephropathy: a case series
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2369
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Combination therapy with rituximab, low-dose cyclophosphamide, and prednisone for idiopathic membranous nephropathy: a case series ; volume:18 ; number:1 ; day:1 ; month:2 ; year:2017 ; pages:1-10 ; date:12.2017
BMC nephrology ; 18, Heft 1 (1.2.2017), 1-10, 12.2017
- Urheber
-
Cortazar, Frank B.
- Beteiligte Personen und Organisationen
-
Leaf, David E.
Owens, Charles T.
Laliberte, Karen
Pendergraft, William F.
Niles, John L.
SpringerLink (Online service)
- DOI
-
10.1186/s12882-017-0459-z
- URN
-
urn:nbn:de:101:1-2018091512181304419722
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:22 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Cortazar, Frank B.
- Leaf, David E.
- Owens, Charles T.
- Laliberte, Karen
- Pendergraft, William F.
- Niles, John L.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Treatment of Membranous Nephropathy in Chinese Patients: Comparison of Rituximab and Intravenous Cyclophosphamide with Steroids
Comparations of efficacy and safety of rituximab, calcineurin inhibitors and cyclophosphamide in primary membranous nephropathy: a single-center retrospective analysis
Cyclophosphamide induced early remission and was superior to rituximab in idiopathic membranous nephropathy patients with high anti-PLA2R antibody levels
Rituximab may affect T lymphocyte subsets balance in primary membranous nephropathy
Lupus Membranous Nephropathy
Perspectives in membranous nephropathy
Rituximab Treatment in a Patient with Kimura Disease and Membranous Nephropathy: Case Report
Monthly mini-dose rituximab for primary anti-PLA2R-positive membranous nephropathy: a personalized approach
C4d immunohistochemistry in membranous nephropathy
Membranous nephropathy: a retrospective observational study of membranous nephropathy in north east and central London
Antigen-specific therapies of membranous nephropathy
Efficacy and safety of rituximab in patients with PLA2R associated membranous nephropathy and resolved HCV infection
Treatment of Membranous Nephropathy in Chinese Patients: Comparison of Rituximab and Intravenous Cyclophosphamide with Steroids
Comparations of efficacy and safety of rituximab, calcineurin inhibitors and cyclophosphamide in primary membranous nephropathy: a single-center retrospective analysis
Cyclophosphamide induced early remission and was superior to rituximab in idiopathic membranous nephropathy patients with high anti-PLA2R antibody levels
Rituximab may affect T lymphocyte subsets balance in primary membranous nephropathy
Lupus Membranous Nephropathy
Perspectives in membranous nephropathy
Rituximab Treatment in a Patient with Kimura Disease and Membranous Nephropathy: Case Report
Monthly mini-dose rituximab for primary anti-PLA2R-positive membranous nephropathy: a personalized approach
C4d immunohistochemistry in membranous nephropathy
Membranous nephropathy: a retrospective observational study of membranous nephropathy in north east and central London
Antigen-specific therapies of membranous nephropathy
Efficacy and safety of rituximab in patients with PLA2R associated membranous nephropathy and resolved HCV infection
Treatment of Membranous Nephropathy in Chinese Patients: Comparison of Rituximab and Intravenous Cyclophosphamide with Steroids
Comparations of efficacy and safety of rituximab, calcineurin inhibitors and cyclophosphamide in primary membranous nephropathy: a single-center retrospective analysis
Cyclophosphamide induced early remission and was superior to rituximab in idiopathic membranous nephropathy patients with high anti-PLA2R antibody levels
Rituximab may affect T lymphocyte subsets balance in primary membranous nephropathy
Lupus Membranous Nephropathy
Perspectives in membranous nephropathy
Rituximab Treatment in a Patient with Kimura Disease and Membranous Nephropathy: Case Report
Monthly mini-dose rituximab for primary anti-PLA2R-positive membranous nephropathy: a personalized approach
C4d immunohistochemistry in membranous nephropathy
Membranous nephropathy: a retrospective observational study of membranous nephropathy in north east and central London
Antigen-specific therapies of membranous nephropathy